Page 17 - Sharekhan Dua News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sharekhan dua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sharekhan Dua Today - Breaking & Trending Today
Sharekhan is bullish on HCL Technologies has recommended buy rating on the stock with a target price of Rs 1780 in its research report dated January 12, 2024. ....
Sharekhan is bullish on Infosys has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated January 12, 2024. ....
Sharekhan is bullish on Infosys has recommended buy rating on the stock with a target price of Rs 615 in its research report dated January 12, 2024. ....
Lupin s focus on the US portfolio is to increase dollar sales to above $200 million from the earlier range of $170-190 million. Lupin recently launched the generic version of asthma treatment drug Spiriva, which is gaining momentum. Sharekhan believes Lupin will not face competition until FY26. ....